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Studies in Western countries have suggested an increasing
incidence of nephrolithiasis (NL) in the latter part of the 20th
century. Therefore, we updated NL epidemiology data for the
Rochester population over the years 1970–2000. All
Rochester residents with any diagnostic code that could be
linked to NL in the years of 1970, 1980, 1990, and 2000 were
identified, and the records reviewed to determine if they met
the criteria for a symptomatic kidney stone as defined in a
previous Rochester, MN study. Age-adjusted incidence
(7s.e.) of new onset symptomatic stone disease for men was
155.1 (728.5) and 105.0 (716.8) per 100 000 per year in
1970 and 2000, respectively. For women, the corresponding
rates were 43.2 (714.0) and 68.4 (712.3) per 100 000 per
year, respectively. On average, rates for women increased by
about 1.9% per year (P¼ 0.064), whereas rates for men
declined by 1.7% per year (P¼ 0.019). The overall man to
woman ratio decreased from 3.1 to 1.3 during the 30 years
(P¼ 0.006). Incident stone rates were highest for men aged
60–69 years, whereas for women, they plateaued after age
30. Therefore, since 1970 overall NL incidence rates in
Rochester have remained relatively flat. However, NL rates for
men have declined, whereas rates for women appear to be
increasing. The reasons remain to be determined.
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Nephrolithiasis (NL) is a common disorder responsible for
substantial human suffering and economic cost to society.
Renal stones have long been associated with affluence,1 and
dietary factors associated with higher socioeconomic status
have been implicated.2 Studies over the last half century,
including recently,3,4 suggest that the incidence has been
steadily increasing, presumably related to diet and lifestyle
changes. In 1979, researchers at Mayo Clinic carefully
examined the epidemiology of kidney stone disease in
Rochester, MN, USA.5 Between 1950 and 1974, 672 incident
cases of symptomatic NL were identified. A trend for a
steadily increasing rate of incident stones over the study
period was apparent, particularly in men, in this seminal
report describing NL epidemiology in a community-based
cohort. We now report an update of the incidence of
symptomatic renal stones in Rochester, MN to determine if
these trends persist.
RESULTS
There were 41, 58, 78, and 71 cases that met our criteria for
incident symptomatic stones in 1970, 1980, 1990, and 2000,
respectively (Table 1). Radiographic confirmation was
obtained in 177 cases (72% of the 248 incident cases). The
mean age at incident stone event was 44.8 years in men and
40.9 years in women. Among the 248 incident cases, the
overall man to woman ratio was 1.73; however, it decreased
from 3.1 to 1.3 over the 30-year period (Figure 1). For
reference, Figure 1 includes incidence rates from the previous
Rochester, MN, USA study for calendar years 1950–1974,5
demonstrating that incidence rates correlate in the time
period of overlap (B1970). From 1970 to 2000, men
experienced a significant average decline in incident stone
rates of 1.7% per year (age-adjusted P¼ 0.019), whereas rates
for women increased by 1.9% per year (age-adjusted
P¼ 0.064), despite a slight decline from 1990 to 2000
(Table 1). Comparison of these trends between men and
women was statistically significant (P¼ 0.006 for test of
interaction between sex and calendar year).
In Figure 2, rates of incident stone events were averaged
over the 4 years 1970, 1980, 1990, and 2000, and are shown
for men and women by decade of age. Overall, incident
stones were distinctly more common for men aged 60–69
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years over this time period. Among women, incident stone
rates were less overall, and roughly equivalent between ages
20 and 70 years, although slightly more common for those
30–39 and 60–69 years (Figure 2). When broken down by
calendar year and age group, the decline in incident stone
events for men was apparent for all age groups, except those
over 70 years (Figure 3); however, only for the 20–29 years age
group was the decline statistically significant (P¼ 0.028). In
women, rates appeared to generally increase across all age
groups (Figure 4), with those aged 20–29 years exhibiting a
sevenfold rise between 1970 and 2000 (P¼ 0.014); trends
over time in other age groups did not reach statistical
significance.
Primary stone type was known for 153 of 248 incident
cases (62%), among which 74% (113) were calcium oxalate,
20% (31) calcium phosphate and 6% (9) uric acid. Men were
somewhat more likely to have calcium oxalate stones than
women (78 vs 67%, P¼ 0.10 adjusted for age and year using
logistic regression) and hence less likely to have calcium
phosphate stones (15 vs 29%, P¼ 0.029). Table 2 provides
the distribution by type for each calendar year of study.
There were no significant time trends in the proportion with
each of the major stone types (P¼ 0.57 calcium oxalate,
P¼ 0.96 for calcium phosphate, adjusting for age and
gender). Owing to the large number of events for which
type was unknown, it was not possible to estimate incidence
rates for each stone type.
The rate for all symptomatic stone events (incident plus
recurrent, men and women) appears to have remained
relatively flat for both sexes over the years 1970–2000
(P¼ 0.33 for trends over time, Table 3). Therefore, the
overall health burden of symptomatic stone disease has
remained constant over the past 30 years in Rochester.
DISCUSSION
Kidney stones are common, with some estimates suggesting
they affect 12% of men and 5% of women in industrialized
Table 1 | Incident symptomatic stone rates in Rochester, MN, USA by decade
Men Women Total
Year Rate (7s.e.)a Cases Rate (7s.e.)a Cases Rate (7s.e.)b Cases
1970 155.1 (728.5) 31 43.2 (714.0) 10 98.7 (715.7) 41
1980 183.7 (729.3) 42 53.6 (713.8) 16 116.5 (715.8) 58
1990 144.0 (722.3) 44 92.4 (716.3) 34 117.1 (713.6) 78
2000 105.0 (716.8) 40 68.4 (712.3) 31 85.1 (710.2) 71
Total 140.6 (711.4) 157 65.8 (77.0) 91 101.8 (76.6) 248
aAnnual age-adjusted (to US 2000 census data) rate of new onset stone disease per 100 000 population.
bAnnual age- and sex-adjusted (to US 2000 census data) rate of new onset stone disease per 100 000 population.
0
20
40
60
80
100
120
140
160
180
1945 1965 1985 2005
Year
In
ci
de
nt
 s
to
ne
s 
pe
r 1
00
 0
00
Overall women 1970–2000
Overall men 1970–2000
Overall women 1950–1974
Overall men 1950–1974
Figure 1 | Incident symptomatic stone rates 1950–2000. Solid lines
depict data form the current Rochester, MN study (1970–2000). For
comparison, the dotted lines indicate data from the previous
Rochester, MN, USA study by Johnson et al. (1950–1974).5 To facilitate
comparison between the two studies, as in the earlier report, all rates
are age adjusted to the 1960 US white population.
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Figure 2 | Incident symptomatic stone rates by age group for men
and women in Rochester, MN, USA between 1970 and 2000,
averaged for the years 1970–2000.
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Figure 3 | Incident symptomatic stone rates in Rochester, MN, USA
1970–2000 for men by age group between the years 1970–2000.
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countries by age 70,6 which extrapolates to 900 000 persons in
the United States each year.7 Correspondingly, the economic
impact in the United States was recently estimated in one
study at $2.1 billion per year8 to as much as $5.3 billion in
another,9 with the vast majority ($4.5 billion) attributed to
direct medical costs. Even though newer techniques such as
extracorporeal shock wave lithotripsy and percutaneous
lithotomy can dislodge and remove even large stones, these
procedures are expensive, and their longer-term renal
consequences are unknown.10–12 Therefore, accurate infor-
mation about stone incidence rates has obvious health and
economic implications.
Recent reports suggest a continuing upward trend in stone
rates. For example, between 1979 and 2000, the incidence
increased nearly threefold in Germany (0.54–1.47%), with a
resulting rise in prevalence from 4.0 to 4.7% among the
population as a whole. Among German men aged 50–64
years, the prevalence was even higher at 9.7%, and over 40%
of the stone formers were recurrent.3 Recently, in the United
States the prevalence of renal stones was noted to increase in
both men (4.9–6.3%) and women (2.8–4.1%) between the
2nd (1976–1980) and 3rd (1988–1994) National Health and
Nutrition Examination Surveys.4 Importantly, in both the
German and American studies, stone rates were determined
by self-reported survey of healthier and younger volunteer
participants as compared to our study, which obtained rates
for all members of a geographically defined population.
Differences in subject selection (volunteers vs all residents),
event rates (incidence vs prevalence), and case identification
(self-report vs medical record review) make comparison of
time trends across studies difficult.
The previous Rochester, MN, USA study demonstrated an
upward trend of stone incidence rates between the years of
1950 and 1974, particularly in men.5 Using the same criteria
to identify symptomatic stone events, our study suggests that
these dynamics may now be changing. Incidence rates for
men continued to rise through 1980, but appear to have
fallen since. In contrast, for women the incidence rates
continued to rise through at least 1990, although they may
have declined over the last decade. A dramatic increase
among those aged 20–29 years appears to account for the
increase of stone events in women. Overall, for incident
symptomatic stones, the man to woman ratio of 3.2 in 1970
fell to 1.3 in 2000 (Figure 1), although the total rates for
both sexes, including both incident and recurrent sympto-
matic stones, have remained relatively flat for the past 30
years (Table 3).
By design we included only symptomatic stones, so that our
present rates would be comparable to those previously reported
for this population5 and provide a direct indication of any
changes in stone occurrence rates. It is possible that increasing
utilization of high-resolution imaging technology, especially
computed tomography scanning, could increase the detection
of incidental (asymptomatic) stone rates. Diagnosis of these
asymptomatic stones could potentially result in additional
stone removal procedures, dietary advice or possibly even
medications, any of which could potentially decrease stone
growth and/or future symptomatic stone episodes.
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Figure 4 | Incident symptomatic stone rates in Rochester, MN,
USA 1970–2000 for women by age group between the years
1970–2000.
Table 2 | Incident symptomatic stone types in Rochester, MN,
USA by decade
Year of diagnosis
1970 1980 1990 2000
Total stones 41 58 78 71
Stone type known: number
(% of total)
18 (44) 32 (55) 41 (53) 62 (87)
% Calcium Oxalate 72.2 78.1 70.7 74.2
% Calcium Phosphate 22.2 12.5 29.3 17.7
% Uric Acid 5.6 9.4 0 8.1
Values are the percent of a given stone type among those incident cases with
analyses available. Stones were classified based upon the major (450%)
component.
Table 3 | Total (incident and recurrent) symptomatic stone rates in Rochester, MN, USA by decade
Men Women Total
Year Rate (7s.e.)a Cases Rate (7s.e.)a Cases Rate (7s.e.)b Cases
1970 189.0 (731.8) 37 47.8 (74.8) 11 116.8 (717.1) 48
1980 229.7 (732.8) 52 59.4 (714.2) 19 142.2 (717.5) 71
1990 171.6 (724.2) 53 107.2 (717.4) 40 138.1 (714.7) 93
2000 125.9 (718.4) 48 77.7 (713.2) 35 100.1 (711.0) 83
Total 170.1 (712.5) 190 75.4 (77.5) 105 121.0 (77.2) 295
aAnnual age-adjusted (to US 2000 census data) rate of new onset stone disease per 100 000 population.
bAnnual age- and sex-adjusted (to US 2000 census data) rate of new onset stone disease per 100 000 population.
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Alternatively, the epidemiology of stone disease could have
changed over the past 20 years. If so, one might speculate that
important dietary or lifestyle changes could be responsible, as
these are known to influence stone formation rates.13–21 For
example, among women low dietary calcium intake correlates
with increased stone risk,14 although the underlying mechan-
isms are not clear.22 Nevertheless, declining consumption of
calcium-rich dairy products among younger women, as has
been documented in certain populations,23 is one potential
factor that could contribute to the increasing incident stone
rates we observed among this group (Figure 4).
In summary, our data suggest that, in Rochester over the
past 20 years, rates of incident symptomatic stones have
fallen in men, but increased in women. Explanations remain
to be investigated, but could involve utilization of imaging
technology or changes in diet and lifestyle.
MATERIALS AND METHODS
Study setting: Rochester Epidemiology Project
Olmsted County, MN, USA (2000 census population, 124 277) and
its central city Rochester (2000 census population, 85 806) are
located in the southeastern part of the State, approximately
128 km from the nearest major metropolitan area. Population-based
epidemiologic research in Olmsted County is facilitated by its
relative geographic isolation. Nearly all of the medical care delivered
to Olmsted County residents is provided by either the Mayo Clinic
or the Olmsted Medical Center and their respective affiliated
hospitals.24 Since 1907, every Mayo Clinic patient has been assigned
a unique identifier, and all information from every contact is
contained within a single dossier (including office, emergency
department, and nursing home visits and hospital in-patient or
outpatient admissions). This detailed information includes a
medical history, clinical assessments, consultation reports, dismissal
summaries, laboratory and radiology results, and correspondence.
The diagnoses assigned at each visit are coded and entered
into continuously updated computer files. These files constitute
the Rochester Epidemiology Project diagnostic index. With
funding from the National Institutes of Health (Grant AR 30582),
the diagnostic index and record linkage was expanded to include the
other providers of medical care to local residents, including
the Olmsted Medical Center and the few private practitioners in
the area. Thus, the details of almost all of the medical care provided
to the residents of Rochester are available for study.24
Sample description
This study was approved by the Mayo Clinic and Olmsted Medical
Center Institutional Review Boards. Rochester Epidemiology
Project resources were used to identify all Rochester residents
with any Mayo diagnostic code that could possibly be linked to NL
in the years of 1970 (n¼ 68), 1980 (n¼ 91), 1990 (n¼ 107) and
2000 (n¼ 107) (Mayo diagnostic index codes 5920, 5921, 5940,
5949, 14675, 15672, 15673, and 15674; equivalent ICD-9-CM
codes25 592, 594 and 275.11). In accordance with Minnesota
state law,24 three patients who did not grant access to their
records for research were deleted from further review. As defined in
detail in the previous study,5 the provider-linked detailed medical
records of the remaining potential cases (n¼ 370) were reviewed to
determine if they met the criteria for a symptomatic kidney
stone event while a resident of Rochester, and whether the event
was incident or recurrent. Kidney stone passage was classified as
confirmed if the patient presented with a characteristic pattern of
flank pain of sudden onset with radiation to the groin (renal colic).
If the pain was atypical, additional evidence, either hematuria or
radiographic confirmation, was required. Persons who had
asymptomatic stones (e.g., detected incidentally on an imaging
study), simple bladder stones or those who manifested other
primary problems that might have secondarily caused the stones
(e.g., ureteral reflux with urinary tract infection, fat malabsorption
or cystinuria) were excluded.5 Age, sex and, if available, stone type
were noted.
Of the 370 potential cases, 344 met the criteria for confirmed
symptomatic stone events while a Rochester resident. The reasons
for exclusion were as follows: three were non-Rochester residents at
the time of stone diagnosis, 19 did not meet the pre-established
criteria for a symptomatic stone event, two did not have sufficient
material in the medical record for determination and two had
evidence of infection-mediated disease (struvite stones). Of the
344 confirmed kidney stone events, 248 were incident and 96
were recurrent.
Statistical analysis
Age group (o20, 20–29, 30–39, 40–49, 50–59, 60–69 and 70þ years)
and gender-specific incidence rates for each calendar year (1970,
1980, 1990 and 2000) were calculated by dividing the number of
cases by the estimated Rochester population in that year as
determined by the US decennial census. Poisson regression was
used to assess gender and age effects and to test for time trends in
incidence using the 56 data points determined by all combinations
of calendar year, gender and age group. Adjusted incidence rates and
s.e. were calculated using the direct method and the sex and age
distribution of the US 2000 total population, except in Figure 1,
where the 1960 US white population was used instead in order to
allow comparison with our earlier study.5
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